This case study is focused on supply chain resilience and innovation in global healthcare markets. Please see the news articles below:
Deloitte: “Top 10 health care innovations,” Link: https://www2.deloitte.com/us/en/pages/life– sciences–and–health–care/articles/top–10–health–care–innovations.html
Article: “National Dialogue for Healthcare Innovation: Framework for Private–Public
Collaboration on Disaster Preparedness and Response,” Link: https://www.hlc.org/wp–content/uploads/2021/01/disaster_preparedness_report–FINAL.pdf Wall Street Journal: “Virus Research Has Exploded Since Covid–19 Hit. Is It Safe?”
Link: https://www.wsj.com/articles/since–covid–19–hit–research–on–viruses–has–exploded–is–it– safe–11632496218?mod=hp_lead_pos8
Wall Street Journal: “Supply–Chain Contracts Get Revamped After Covid–19 Disruptions,” Link: https://www.wsj.com/articles/supplier–contracts–get–revamped–after–covid–19–disruptions– 11632342257?mod=searchresults_pos9&page=1
This case study aims to improve innovation and global supply chains supporting the United States healthcare industry.
Specific topics:
• Provide a summary of healthcare innovations discussed in the Deloitte article.
• Discuss the opportunities for public–private collaboration in healthcare.
• Discuss how healthcare organizations could use supplier diversity and sustainability to manage new healthcare innovations in the future.
• Discuss the future advantages of open innovation for new product development in health care.
o Article 1: Supplier Innovation Push
o Article 2: Customer and Supplier Collaboration
o Article 3: Managing Innovation Dilemmas